Association of the Time to Immune Checkpoint Inhibitor (ICI) Initiation and Outcomes With Second Line ICI in Patients With Advanced Urothelial Carcinoma
Resource Type
Article
Authors
Talukder, Rafee ; Makrakis, Dimitrios ; Lin, Genevieve Ihsiu ; Diamantopoulos, Leonidas N. ; Dawsey, Scott ; Gupta, Shilpa ; Carril-Ajuria, Lucia ; Castellano, Daniel ; de Kouchkovsky, Ivan ; Jindal, Tanya ; Koshkin, Vadim S. ; Park, Joseph J. ; Alva, Ajjai ; Bilen, Mehmet A. ; Stewart, Tyler F. ; McKay, Rana R. ; Tripathi, Nishita ; Agarwal, Neeraj ; Vather-Wu, Naomi ; Zakharia, Yousef ; Morales-Barrera, Rafael ; Devitt, Michael E. ; Cortellini, Alessio ; Fulgenzi, Claudia Angela Maria ; Pinato, David J. ; Nelson, Ariel ; Hoimes, Christopher J. ; Gupta, Kavita ; Gartrell, Benjamin A. ; Sankin, Alex ; Tripathi, Abhishek ; Zakopoulou, Roubini ; Bamias, Aristotelis ; Murgic, Jure ; Fröbe, Ana ; Rodriguez-Vida, Alejo ; Drakaki, Alexandra ; Liu, Sandy ; Lu, Eric ; Kumar, Vivek ; Lorenzo, Giuseppe Di ; Joshi, Monika ; Isaacsson-Velho, Pedro ; Buznego, Lucia Alonso ; Duran, Ignacio ; Moses, Marcus ; Barata, Pedro ; Sonpavde, Guru ; Wright, Jonathan L. ; Yu, Evan Y. ; Montgomery, Robert Bruce ; Hsieh, Andrew C. ; Grivas, Petros ; Khaki, Ali Raza
Source
In Clinical Genitourinary Cancer December 2022 20(6):558-567
Subject
Language
ISSN
1558-7673